At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 61 enrolled
Drug / intervention
MT-6548 +4 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Clinical Pharmacological Study to Evaluate the Effects of Iron Supplements on the Pharmacokinetics of MT-6548 in Healthy Male Volunteers
In Brief
A Phase 3 clinical trial evaluating MT-6548, Iron supplement A, and 3 other interventions for Healthy. Completed, enrolled 61 participants across 1 site.
Detailed Summary
The objectives of this study are to investigate the pharmacokinetics and safety of MT-6548 co-administered with iron supplements in healthy male volunteers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesJapan
Collaborators--
Timeline
Phase 3CompletedFinished
20192020202120222023202420252026
First PostedAug 2018
Enrollment StartAug 2018
Primary CompletionSep 2018
TodayJul 2026
First PostedAug 24, 2018
Enrollment StartAug 27, 2018
Primary CompletionSep 30, 2018
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 7.9 years ago
Interventions
MT-6548drug
Oral tablet
Iron supplement Adrug
Oral tablet
Iron supplement Bdrug
Oral tablet
Iron supplement Cdrug
Oral tablet
Iron supplement Ddrug
Oral tablet